Terns’ oral GLP-1 pass­es Phase 1 test with promis­ing weight loss af­ter one month

Terns Phar­ma­ceu­ti­cals un­veiled ear­ly-phase weight loss da­ta from an oral GLP-1 ag­o­nist that it says could be more tol­er­a­ble at high­er dos­es than cur­rent­ly mar­ket­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER